Improving myelin repair in multiple sclerosis by enhancing debris clearance and lipid production.
Promoting remyelination in multiple sclerosis by simultaneously modulating myelin debris clearance and myelin lipid synthesis
This study is looking for new ways to help people with multiple sclerosis repair the protective covering around their nerves by focusing on a special protein called Quaking, which could help clear out damaged parts and make new myelin, ultimately aiming to improve nerve function.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11123090 on NIH RePORTER |
What this research studies
This research focuses on finding new ways to promote the repair of myelin in patients with multiple sclerosis (MS), a condition where the immune system damages the protective covering of nerves. The approach involves enhancing the clearance of damaged myelin debris and boosting the production of new myelin lipids. Researchers have identified a protein called Quaking (Qki) that plays a crucial role in these processes. By targeting Qki, the study aims to improve the ability of the central nervous system to regenerate myelin and restore nerve function.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have been diagnosed with multiple sclerosis.
Not a fit: Patients with other neurological conditions unrelated to demyelination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that not only alleviate symptoms of multiple sclerosis but also promote actual healing of nerve damage.
How similar studies have performed: Previous research has shown promise in targeting myelin repair mechanisms, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Hu, Jian — University of Tx Md Anderson Can Ctr
- Study coordinator: Hu, Jian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.